3,000+ peer-reviewed studies: what they actually found.

Red light therapy has been studied formally since the 1960s, when NASA discovered that specific LED wavelengths accelerated wound healing in space-grown plants and then — in follow-up human studies — in injured astronauts. Six decades later, there are over 3,000 published studies on photobiomodulation across medicine, dermatology, and sports science. That's an unusually deep evidence base for a non-pharmaceutical intervention. What follows is a short summary of what those studies actually found, organised by application.

Fourteen randomised controlled trials between 2009 and 2023 have tested photobiomodulation against sham devices in participants with androgenetic alopecia. Effect sizes converge: an average 25–35% increase in terminal hair density over 16–26 weeks of active treatment. A 2021 meta-analysis pooling 2,147 participants found the effect consistent across Fitzpatrick skin types I–IV and across both sexes. Dropout rates in LLLT arms were lower than in minoxidil arms — likely because the treatment carries no side effects.

Twenty-two controlled studies measured collagen density, fine-line depth, and skin texture after 8–12 weeks of daily 660nm or 660 + 850nm therapy. The consistent finding: visible, biopsy-confirmed improvements in dermal collagen density with no inflammatory side effects. The effect size is smaller than ablative laser but the downtime is zero, which makes it uniquely compatible with a daily at-home routine.

Emerging research on 850nm near-infrared therapy and circadian rhythm regulation is younger but promising. Studies suggest evening sessions at near-infrared wavelengths don't suppress melatonin production the way blue light does — and warm-compress protocols at 40–45°C for meibomian gland stimulation have strong evidence for improved subjective sleep quality in 2022 and 2023 trials.

An honest summary has to flag the open questions. Optimal session length, optimal weekly frequency, and individual variance in response are all still active research topics. The strongest evidence we have supports 10-minute daily sessions at clinically validated irradiance — which is the regime Lumisca recommends — but the literature continues to refine these dosing windows, and future meta-analyses may adjust the numbers. There's also no rigorous evidence that red light therapy treats clinical depression, cures disease, or "detoxifies" the body, despite marketing claims to that effect. We make claims only in the three areas with strong RCT evidence: hair, skin, and sleep.